リファンピシン、カルバマゼピン、セイヨウオトギリソウ含有食品

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. C型肝炎ウイルス感染治療のための直接作用型抗ウイルス薬direct acting antivirals for the treatment of hepatitis c virus infection [show details]
…HCV protease inhibitors. Sofosbuvir is a substrate of the P-glycoprotein (P-gp) drug transporter, so drugs that are potent intestinal P-gp inducers may decrease sofosbuvir levels. Thus, coadministration of …
2. リファマイシン（リファンピン、リファブチン、リファペンチン）rifamycins rifampin rifabutin rifapentine [show details]
… antituberculous drugs are discussed separately. Rifampin is a potent inducer of several drug-metabolizing enzymes as well as P-glycoprotein (P-gp) multidrug efflux transporters, which can lead to undetectable …
3. ジゴキシンによる治療：初回投与、モニタリング、および用量変更treatment with digoxin initial dosing monitoring and dose modification [show details]
…inhibit P-glycoprotein is provided separately Inducers of P-glycoprotein (eg, phenytoin, rifampin, etc), on the other hand, can decrease serum digoxin levels. A list of medicines that induce P-glycoprotein …
4. エキノカンジンの薬理学pharmacology of echinocandins [show details]
…have not been performed. Echinocandins are not significant inhibitors or inducers of cytochrome P450 metabolism or p-glycoprotein drug efflux transporters. As a result, echinocandins generally have a lower …
5. 第二世代抗精神病薬：薬理学、用法および副作用second generation antipsychotic medications pharmacology administration and side effects [show details]
…paliperidone when a strong inducer of both CYP 3A4 and P-glycoprotein 1 (eg, carbamazepine, rifampin, St. John wort) is co-administered. Conversely, on discontinuation of the strong inducer, it may be necessary …